266 related articles for article (PubMed ID: 21510725)
21. Inhaled iloprost for the control of pulmonary hypertension.
Krug S; Sablotzki A; Hammerschmidt S; Wirtz H; Seyfarth HJ
Vasc Health Risk Manag; 2009; 5(1):465-74. PubMed ID: 19475782
[TBL] [Abstract][Full Text] [Related]
22. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
[TBL] [Abstract][Full Text] [Related]
23. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.
Stricker H; Domenighetti G; Fiori G; Mombelli G
Schweiz Med Wochenschr; 1999 Jun; 129(24):923-7. PubMed ID: 10413827
[TBL] [Abstract][Full Text] [Related]
24. Aerosolized vasodilators in pulmonary hypertension.
Gessler T; Schmehl T; Olschewski H; Grimminger F; Seeger W
J Aerosol Med; 2002; 15(2):117-22. PubMed ID: 12184861
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.
Olschewski H; Rohde B; Behr J; Ewert R; Gessler T; Ghofrani HA; Schmehl T
Chest; 2003 Oct; 124(4):1294-304. PubMed ID: 14555558
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
Opitz CF; Wensel R; Winkler J; Halank M; Bruch L; Kleber FX; Höffken G; Anker SD; Negassa A; Felix SB; Hetzer R; Ewert R
Eur Heart J; 2005 Sep; 26(18):1895-902. PubMed ID: 15888496
[TBL] [Abstract][Full Text] [Related]
27. [Clinical utility of inhaled iloprost in pulmonary arterial hypertension].
Santos-Martínez LE; Moreno-Ruiz LA; Jiménez-Santos M; Olmos-Temois SG; Bojorquez-Guerrero LA; Baranda-Tovar FM
Arch Cardiol Mex; 2014; 84(3):202-10. PubMed ID: 25001057
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
[TBL] [Abstract][Full Text] [Related]
29. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
[TBL] [Abstract][Full Text] [Related]
30. Aerosolized iloprost customized for the critically ill.
Harris KW; O'Riordan TG; Smaldone GC
Respir Care; 2007 Nov; 52(11):1507-9. PubMed ID: 17971254
[TBL] [Abstract][Full Text] [Related]
31. Is it safe to use inhaled iloprost in infants with pulmonary hypertension?
Karaagaç AT; Yildirim AI
Indian Pediatr; 2013 Nov; 50(11):1064-5. PubMed ID: 24382910
[No Abstract] [Full Text] [Related]
32. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
[TBL] [Abstract][Full Text] [Related]
33. Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
Hoeper MM; Seyfarth HJ; Hoeffken G; Wirtz H; Spiekerkoetter E; Pletz MW; Welte T; Halank M
Eur Respir J; 2007 Dec; 30(6):1096-102. PubMed ID: 17652314
[TBL] [Abstract][Full Text] [Related]
34. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
Gessler T; Seeger W; Schmehl T
Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
[TBL] [Abstract][Full Text] [Related]
35. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension.
Onen ZP; Akkoca Yildiz O; Eriş Gülbay B; Karabiyikoğlu G
Tuberk Toraks; 2006; 54(2):177-81. PubMed ID: 16924576
[TBL] [Abstract][Full Text] [Related]
36. Aerosolized prostacyclins.
Siobal M
Respir Care; 2004 Jun; 49(6):640-52. PubMed ID: 15165299
[TBL] [Abstract][Full Text] [Related]
37. [Long-term treatment of primary pulmonary hypertension with inhaled iloprost].
Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
Pneumologie; 2001 Jan; 55(1):38-43. PubMed ID: 11236355
[TBL] [Abstract][Full Text] [Related]
38. Idiopathic pulmonary arterial hypertension and inhaled iloprost: good night rebound effects?
Domenighetti GM
Respiration; 2007; 74(5):496-7. PubMed ID: 17671405
[No Abstract] [Full Text] [Related]
39. Role of Vasodilator Testing in Pulmonary Hypertension.
Sharma A; Obiagwu C; Mezue K; Garg A; Mukherjee D; Haythe J; Shetty V; Einstein AJ
Prog Cardiovasc Dis; 2016; 58(4):425-33. PubMed ID: 26434988
[TBL] [Abstract][Full Text] [Related]
40. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
Olschewski H; Ghofrani HA; Schmehl T; Winkler J; Wilkens H; Höper MM; Behr J; Kleber FX; Seeger W
Ann Intern Med; 2000 Mar; 132(6):435-43. PubMed ID: 10733442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
